Invention Application
- Patent Title: PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES MEDIATED BY MICROBES
-
Application No.: US17702304Application Date: 2022-03-23
-
Publication No.: US20220218713A1Publication Date: 2022-07-14
- Inventor: Rosemarie Mang , Werner Heilmayer , Rudolf Badegruber , Dirk Strickmann , Rodger Novak , Mathias Ferencic , Atchyuta Rama Chandra Murty Bulusu
- Applicant: NABRIVA THERAPEUTICS GMBH
- Applicant Address: AT A-1112 Wien
- Assignee: NABRIVA THERAPEUTICS GMBH
- Current Assignee: NABRIVA THERAPEUTICS GMBH
- Current Assignee Address: AT A-1112 Wien
- Priority: EP07450053.9 20070320
- Main IPC: A61K31/5375
- IPC: A61K31/5375 ; C07C323/52 ; A61K31/215 ; A61K31/357 ; C07C323/61 ; C07D295/096 ; C07D317/72
Abstract:
Pleuromutilin derivative compounds of the following formula (I), and uses thereof for the treatment of diseases mediated by microbes, are disclosed
Information query
